FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022677829> ?p ?o ?g. }

• W2022677829 endingPage "CMWH.S5149" @default.
• W2022677829 startingPage "CMWH.S5149" @default.
• W2022677829 abstract "Given its increasing incidence and serious complications, osteoporosis requires safe and effective long-term treatment. Strontium ranelate (SR), a new anti-osteoporotic treatment with a unique mode of action, has been investigated in the Spinal Osteoporosis Therapeutic Intervention (SOTI) and the Treatment Of Peripheral OSteoporosis (TROPOS) trials, two major 3-year multinational placebo-controlled Phase III randomized clinical trials. In SOTI, SR treatment reduced the risk of vertebral fracture by 41% (20.9% vs. 32.8%, P < 0.001); in TROPOS, it reduced the risk of non-vertebral fracture by 16% (11.2% vs. 12.9%, P = 0.04), and the risk of hip fracture in patients at high risk by 36% (4.3% vs. 6.4%, P = 0.046). Also SR has been shown to decrease the risk of vertebral fracture after 4 years of treatment and the risk of nonvertebral fracture after 5 years. Also it demonstrated for high risk patients a significant decrease of the risk of hip fractures (–43%) after 5 years of treatment. Unlike antiresorptive agents, SR produced steady and significant BMD increases that correlated directly with decreases in vertebral and hip fracture risk. Preplanned analysis of the pooled dataset from SOTI and TROPOS showed that SR was effective whether or not patients had key risk factors for fractures at baseline. SR was also effective in patients with osteopenia and younger postmenopausal patients aged 50–65 years. It was also effective for preventing both vertebral and nonvertebral fractures in the elderly (>80 years). Also, SR significantly attenuated height loss and decreased back pain. Finally long-term follow-up showed that BMD gains were maintained through a 8 year-period with maintaining the incidence of fracture between the first 3 years and the last 3 years of treatment. The safety profile of SR was almost similar to placebo in both trials. A slight but significant increased risk of thromboembolism events was noted from the pooled phase III studies data. However this increased was not found in a large retrospective observational study. Thus, SR demonstrates broad spectrum safety and efficacy in reducing the risks of both vertebral and non-vertebral (including hip) fractures in a wide variety of patients, and should be considered as a first-line option to treat women at risk of osteoporotic fractures, whatever their age, the severity of the disease, and their risk factors." @default.
• W2022677829 created "2016-06-24" @default.
• W2022677829 creator A5024030389 @default.
• W2022677829 date "2011-01-01" @default.
• W2022677829 modified "2023-09-25" @default.
• W2022677829 title "Treatment of Postmenopausal Osteoporosis: Focus on Strontium Ranelate" @default.
• W2022677829 cites W1916689057 @default.
• W2022677829 cites W1965256710 @default.
• W2022677829 cites W1970001479 @default.
• W2022677829 cites W1978611346 @default.
• W2022677829 cites W1980688132 @default.
• W2022677829 cites W1985184665 @default.
• W2022677829 cites W1987613663 @default.
• W2022677829 cites W1997265082 @default.
• W2022677829 cites W2000383425 @default.
• W2022677829 cites W2004201886 @default.
• W2022677829 cites W2005336924 @default.
• W2022677829 cites W2008466579 @default.
• W2022677829 cites W2009508470 @default.
• W2022677829 cites W2012044560 @default.
• W2022677829 cites W2013724724 @default.
• W2022677829 cites W2031475283 @default.
• W2022677829 cites W2036473416 @default.
• W2022677829 cites W2042450573 @default.
• W2022677829 cites W2045798461 @default.
• W2022677829 cites W205011652 @default.
• W2022677829 cites W2065242899 @default.
• W2022677829 cites W2065916720 @default.
• W2022677829 cites W2071494980 @default.
• W2022677829 cites W2073149231 @default.
• W2022677829 cites W2075580296 @default.
• W2022677829 cites W2076136326 @default.
• W2022677829 cites W2098692086 @default.
• W2022677829 cites W2106286936 @default.
• W2022677829 cites W2107490395 @default.
• W2022677829 cites W2111409841 @default.
• W2022677829 cites W2116605720 @default.
• W2022677829 cites W2119062112 @default.
• W2022677829 cites W2128986278 @default.
• W2022677829 cites W2145931121 @default.
• W2022677829 cites W2145955243 @default.
• W2022677829 cites W2151010429 @default.
• W2022677829 cites W2155057203 @default.
• W2022677829 cites W2157078562 @default.
• W2022677829 cites W2162150486 @default.
• W2022677829 cites W2163554085 @default.
• W2022677829 cites W2412867048 @default.
• W2022677829 cites W2622381248 @default.
• W2022677829 cites W3044286197 @default.
• W2022677829 doi "https://doi.org/10.4137/cmwh.s5149" @default.
• W2022677829 hasPublicationYear "2011" @default.
• W2022677829 type Work @default.
• W2022677829 sameAs 2022677829 @default.
• W2022677829 citedByCount "0" @default.
• W2022677829 crossrefType "journal-article" @default.
• W2022677829 hasAuthorship W2022677829A5024030389 @default.
• W2022677829 hasBestOaLocation W20226778291 @default.
• W2022677829 hasConcept C120665830 @default.
• W2022677829 hasConcept C121332964 @default.
• W2022677829 hasConcept C126322002 @default.
• W2022677829 hasConcept C141071460 @default.
• W2022677829 hasConcept C142724271 @default.
• W2022677829 hasConcept C204787440 @default.
• W2022677829 hasConcept C27081682 @default.
• W2022677829 hasConcept C2776541429 @default.
• W2022677829 hasConcept C2776594446 @default.
• W2022677829 hasConcept C2776886416 @default.
• W2022677829 hasConcept C2777083390 @default.
• W2022677829 hasConcept C61511704 @default.
• W2022677829 hasConcept C71924100 @default.
• W2022677829 hasConceptScore W2022677829C120665830 @default.
• W2022677829 hasConceptScore W2022677829C121332964 @default.
• W2022677829 hasConceptScore W2022677829C126322002 @default.
• W2022677829 hasConceptScore W2022677829C141071460 @default.
• W2022677829 hasConceptScore W2022677829C142724271 @default.
• W2022677829 hasConceptScore W2022677829C204787440 @default.
• W2022677829 hasConceptScore W2022677829C27081682 @default.
• W2022677829 hasConceptScore W2022677829C2776541429 @default.
• W2022677829 hasConceptScore W2022677829C2776594446 @default.
• W2022677829 hasConceptScore W2022677829C2776886416 @default.
• W2022677829 hasConceptScore W2022677829C2777083390 @default.
• W2022677829 hasConceptScore W2022677829C61511704 @default.
• W2022677829 hasConceptScore W2022677829C71924100 @default.
• W2022677829 hasLocation W20226778291 @default.
• W2022677829 hasOpenAccess W2022677829 @default.
• W2022677829 hasPrimaryLocation W20226778291 @default.
• W2022677829 hasRelatedWork W1420838627 @default.
• W2022677829 hasRelatedWork W2028198987 @default.
• W2022677829 hasRelatedWork W2045402476 @default.
• W2022677829 hasRelatedWork W2045798461 @default.
• W2022677829 hasRelatedWork W2048846116 @default.
• W2022677829 hasRelatedWork W2052699956 @default.
• W2022677829 hasRelatedWork W2110967307 @default.
• W2022677829 hasRelatedWork W2125971204 @default.
• W2022677829 hasRelatedWork W2392373393 @default.
• W2022677829 hasRelatedWork W2428783036 @default.
• W2022677829 hasVolume "4" @default.
• W2022677829 isParatext "false" @default.

• next